MarginsXMarginsX
Home › Markets › Health Care › RXST

RxSight Inc. (RXST)

RXST trades on Nasdaq in Health Care, Ophthalmic Goods. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$5.30
-0.38% on the day
Market cap
$222.2M
Micro cap
Revenue · 2025
$134.5M
-3.9% on 2024
Net income · 2025
-$38.9M
-29.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1111485/000119312526071775/0001193125-26-071775-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerRXST on Nasdaq
SectorHealth Care
IndustryOphthalmic Goods
CountryUnited States
IPO year2021
SEC CIK0001111485
SEC industry codeOphthalmic Goods
Incorporated inDE

Financials · 2025

LineValue
Revenue$134.5M
Net income-$38.9M
Operating income-$48.2M
Net margin-29.0%
Operating margin-35.8%
Revenue growth-3.9%
Cash$19.9M
Total assets$311.8M
P/E (computed)Net income was not positive
P/S (computed)1.7×

Warning signs

Cash runway
Cash-flow positive
$66.7M cash at September 30, 2026
Share count, 1 year
+2.0%
2025-10-30 to 2026-10-30 · +16.9% over 3 years
Going-concern doubt
No
10-Q filed November 3, 2026
Insider net buying, 12 months
-$104K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-03
Cash and burn$66.7M cash; operating cash flow $5.9M a quarter.Report 2026-09-30
Shares outstanding41,929,222 (2026-10-30); 41,116,640 a year earlier; 35,861,604 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Irvine, California, United StatesPCAOB Form AP 2026-03-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $104K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$24.6M-$16.2M$45.2M$66.7MNo debt tags$121.8M10-Q 2026-11-03
Q2 2026
2026-06-30
$33.7M-$12.1M-$9.5M$13.4MNo debt tags$127.6M10-Q 2026-08-05
Q1 2026
2026-03-31
$30.9M-$15.9M-$10.9M$17.6MNo debt tags$127.5M10-Q 2026-05-06
Q4 2025
2025-12-31
$32.6M-$9.2M-$1.1M$19.9MNo debt tags$134.5M10-K 2026-02-25
Q3 2025
2025-09-30
$30.3M-$9.8M-$1.2M$29.6MNo debt tags$142.1M10-Q 2026-11-03
Q2 2025
2025-06-30
$33.6M-$11.8M-$4.4M$40.4MNo debt tags$147.1M10-Q 2026-08-05
Q1 2025
2025-03-31
$37.9M-$8.2M-$8.8M$28.0MNo debt tags$148.3M10-Q 2026-05-06
Q4 2024
2024-12-31
$40.2M-$5.9M-$4.3M$16.7MNo debt tags$139.9M10-K 2026-02-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentPOS AM2026-02-25
Latest annual report10-K2026-02-25
Latest quarterly / interim10-Q2026-11-03
Latest current report8-K2026-11-03
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 476 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+17.2%
1 month+17.4%
3 months-24.1%
Year to date-48.9%
1 year-44.5%
From 52-week high-59.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Ophthalmic Goods

TickerCompanyPriceDayMarket cap
STAASTAAR Surgical Company$26.01-1.44%$1.3B
EYENational Vision Holdings Inc.$18.74+2.43%$1.5B
WRBYWarby Parker Inc.$26.23-4.41%$3.3B
LUCYInnovative Eyewear Inc.$0.7820-3.25%$6.8M
BLCOBausch + Lomb Corporation Common Shares$20.88-1.00%$7.5B
COOThe Cooper Companies Inc.$61.88-1.23%$11.8B
ALCAlcon Inc.$73.64-0.65%$36.8B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier